Michael Delacher

5PUBLICATIONS
42CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Rehabilitation engineeringHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Genome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 22, 2025
Induced regulatory T cells for therapy: targeting RBPJ to enhance stability and function.

Niklas Beumer, Michael Delacher

|Jan 16, 2024
The effector program of human CD8 T cells supports tissue remodeling.

Michael Delacher, Lisa Schmidleithner, Malte Simon

|Sep 26, 2022
Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapy.

Sebastian Bittner, Brigitte Ruhland, Veronika Hofmann

|Apr 10, 2019
Rbpj expression in regulatory T cells is critical for restraining T<sub>H</sub>2 responses.

Michael Delacher, Christian Schmidl, Yonatan Herzig

Pageof 1